Literature DB >> 10460106

Tuberculosis due to Mycobacterium bovis in the Australian population: DNA typing of isolates, 1970-1994.

D V Cousins1, S N Williams, D J Dawson.   

Abstract

SETTING: Bacteriologically confirmed cases of Mycobacterium bovis in the Australian population.
OBJECTIVE: To evaluate the DNA fingerprinting techniques commonly used for M. bovis on isolates from humans and determine whether they were useful for determining the origin of human infection.
DESIGN: M. bovis strains isolated between 1970 and 1994 were obtained from five Australian Reference Laboratories. Four DNA fingerprinting techniques, comprising Southern hybridisation with three different probes (the insertion sequence [IS]6110, the polymorphic guanine-cytosine-rich sequence [PGRS] and the direct repeat [DR]) and a PCR-based method (spoligotyping) were used.
RESULTS: The PGRS, DR and IS6110 RFLP methods identified 32, 22 and 14 different types respectively from the 45 isolates available. Spoligotyping identified 18 different types. When all methods were combined 41 different strains were identified. Clear differences were found between many isolates from Australian-born patients and those from patients born overseas.
CONCLUSIONS: The PGRS RFLP method was the most effective method for typing the human strains, but a combination of methods is recommended for maximum sensitivity. Most Australian-born patients that had worked in the meat and livestock industries were infected with strains similar to those that are commonly found in Australian cattle, confirming the occupational risk in these industries. Patients born overseas were typically infected with strains genetically different from those of patients born in Australia. This suggests that patients born overseas identified with M. bovis were presenting with reactivation of infection acquired outside Australia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460106

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Authors:  M M Hannan; E P Desmond; G P Morlock; G H Mazurek; J T Crawford
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Genetic diversity among Mycobacterium bovis isolates: a preliminary study of strains from animal and human sources.

Authors:  M P Sales; G M Taylor; S Hughes; M Yates; G Hewinson; D B Young; R J Shaw
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Association between spoligotype-VNTR types and virulence of Mycobacterium bovis in cattle.

Authors:  Sergio Garbaccio; Analía Macias; Ernesto Shimizu; Fernando Paolicchi; Natalia Pezzone; Gabriel Magnano; Laura Zapata; Alejandro Abdala; Hector Tarabla; Maite Peyru; Karina Caimi; Martín Zumárraga; Ana Canal; Angel Cataldi
Journal:  Virulence       Date:  2014-01-07       Impact factor: 5.882

4.  Spoligotype diversity of Mycobacterium bovis strains isolated in France from 1979 to 2000.

Authors:  N Haddad; A Ostyn; C Karoui; M Masselot; M F Thorel; S L Hughes; J Inwald; R G Hewinson; B Durand
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Occurrence of overlooked zoonotic tuberculosis: detection of Mycobacterium bovis in human cerebrospinal fluid.

Authors:  N P Shah; A Singhal; A Jain; P Kumar; S S Uppal; M V P Srivatsava; H K Prasad
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.

Authors:  Sanjay S Gautam; Micheál Mac Aogáin; Louise A Cooley; Greg Haug; Janet A Fyfe; Maria Globan; Ronan F O'Toole
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.